Lockheed Martin Investment Management CO Pfizer Inc Transaction History

Lockheed Martin Investment Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $6.46 Million - $7.84 Million	-214,609 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $10.5 Million - $15 Million	-388,300 Reduced 64.4%	214,609 $7 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $6.33 Million - $7.19 Million	192,329 Added 46.84%	602,909 $23.6 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $359,989 - $466,800	11,080 Added 2.77%	410,580 $14.8 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $4.96 Million - $5.56 Million	134,000 Added 50.47%	399,500 $17.3 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $9.96 Million - $10.9 Million	265,500 New	265,500 $11.3 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $593,640 - $632,879	-18,000 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$31.91 - $37.02 $574,380 - $666,360	18,000 New	18,000 $0

3,253

3.72B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Lockheed Martin Investment Management CO, based on Form 13F filings with the SEC.

Stay updated on Lockheed Martin Investment Management CO with notifications on news.